GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » EV-to-Revenue

NeuPath Health (TSXV:NPTH) EV-to-Revenue : 0.30 (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NeuPath Health's enterprise value is C$19.55 Mil. NeuPath Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$66.10 Mil. Therefore, NeuPath Health's EV-to-Revenue for today is 0.30.

The historical rank and industry rank for NeuPath Health's EV-to-Revenue or its related term are showing as below:

TSXV:NPTH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.24   Med: 0.36   Max: 0.81
Current: 0.3

During the past 5 years, the highest EV-to-Revenue of NeuPath Health was 0.81. The lowest was 0.24. And the median was 0.36.

TSXV:NPTH's EV-to-Revenue is ranked better than
91.86% of 663 companies
in the Healthcare Providers & Services industry
Industry Median: 1.85 vs TSXV:NPTH: 0.30

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), NeuPath Health's stock price is C$0.18. NeuPath Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.20. Therefore, NeuPath Health's PS Ratio for today is 0.15.


NeuPath Health EV-to-Revenue Historical Data

The historical data trend for NeuPath Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health EV-to-Revenue Chart

NeuPath Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- 0.71 0.56 0.34 0.29

NeuPath Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.30 0.32 0.27 0.29

Competitive Comparison of NeuPath Health's EV-to-Revenue

For the Medical Care Facilities subindustry, NeuPath Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeuPath Health's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NeuPath Health's EV-to-Revenue falls into.



NeuPath Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NeuPath Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=19.547/66.102
=0.30

NeuPath Health's current Enterprise Value is C$19.55 Mil.
NeuPath Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$66.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeuPath Health  (TSXV:NPTH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NeuPath Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.18/1.196
=0.15

NeuPath Health's share price for today is C$0.18.
NeuPath Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeuPath Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NeuPath Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NeuPath Health (TSXV:NPTH) Business Description

Traded in Other Exchanges
N/A
Address
181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

NeuPath Health (TSXV:NPTH) Headlines

No Headlines